|
|
|
|
|
by xienze
2233 days ago
|
|
> can snap it's fingers and compel some private companies that are well positioned to be able to manufacture tests to do so at a higher priority than other business concerns And we’ve done that with things like masks and ventilators. But there is a key limiting factor with the tests, the reagant supply. Again, can’t just snap our fingers and make it happen faster. This isn’t AWS, we can’t just spin up more supply in an instant. |
|
It’s not like every country is getting a ration of the same number of units - so it shouldn’t be harder for large countries. Again this is likely an issue for smaller countries as they have to compete with America for a share of the reagent supply.